Privia Health Group Inc (PRVA) plunged -3.60 in the last month: It’s impossible to believe the numbers

On Tuesday, Privia Health Group Inc (NASDAQ: PRVA) opened lower -3.60% from the last session, before settling in for the closing price of $18.35. Price fluctuations for PRVA have ranged from $17.54 to $30.15 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 20.87% over the past five years. Company’s average yearly earnings per share was noted 27.41% at the time writing. With a float of $101.89 million, this company’s outstanding shares have now reached $118.22 million.

Let’s look at the performance matrix of the company that is accounted for 1102 employees.

Privia Health Group Inc (PRVA) Insider Updates

A key investor’s attitude towards the stock of the Health Information Services industry is another important factor to consider. The insider ownership of Privia Health Group Inc is 14.06%, while institutional ownership is 95.84%. The most recent insider transaction that took place on Apr 02 ’24, was worth 69,889. In this transaction EVP & Chief Financial Officer of this company sold 3,933 shares at a rate of $17.77, taking the stock ownership to the 262,279 shares. Before that another transaction happened on Mar 11 ’24, when Company’s Director sold 400 for $23.02, making the entire transaction worth $9,208. This insider now owns 5,445,018 shares in total.

Privia Health Group Inc (PRVA) Performance Highlights and Predictions

Wall Street market experts anticipate that the next fiscal year will bring earnings of 20.40 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 27.41% per share during the next fiscal year.

Privia Health Group Inc (NASDAQ: PRVA) Trading Performance Indicators

Check out the current performance indicators for Privia Health Group Inc (PRVA). In the past quarter, the stock posted a quick ratio of 1.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.27. Likewise, its price to free cash flow for the trailing twelve months is 26.00.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.19, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.33 in one year’s time.

Technical Analysis of Privia Health Group Inc (PRVA)

Privia Health Group Inc (NASDAQ: PRVA) saw its 5-day average volume 0.88 million, a negative change from its year-to-date volume of 0.96 million. As of the previous 9 days, the stock’s Stochastic %D was 31.60%. Additionally, its Average True Range was 0.84.

During the past 100 days, Privia Health Group Inc’s (PRVA) raw stochastic average was set at 2.22%, which indicates a significant decrease from 5.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.13% in the past 14 days, which was lower than the 49.19% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $20.22, while its 200-day Moving Average is $22.74. Nevertheless, the first resistance level for the watch stands at $18.15 in the near term. At $18.61, the stock is likely to face the second major resistance level. The third major resistance level sits at $18.86. If the price goes on to break the first support level at $17.44, it is likely to go to the next support level at $17.19. Assuming the price breaks the second support level, the third support level stands at $16.73.

Privia Health Group Inc (NASDAQ: PRVA) Key Stats

There are currently 118,656K shares outstanding in the company with a market cap of 2.10 billion. Presently, the company’s annual sales total 1,658 M according to its annual income of 23,080 K. Last quarter, the company’s sales amounted to 440,830 K and its income totaled 2,840 K.